NCT03527563 Study on Internet Medical Models for the Management of Patients With Hypertension in China Status UNKNOWN Phase NA
NCT03525587 Development and Validation of a Self-assessment System Based on a Mobile App to Manage Adult Growth Hormone Deficiency Status COMPLETED Phase NA
NCT03516604 PF-04995274 and Emotional Processing in Un-medicated Depression Status COMPLETED Phase PHASE1
NCT03515200 Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE1
NCT03513588 2-Week Study In People With Nonalcoholic Fatty Liver Disease Status COMPLETED Phase PHASE1
NCT03512288 Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants Status COMPLETED Phase PHASE2
NCT03505554 A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive Lymphoma Status COMPLETED Phase PHASE2
NCT03503474 COMBACTE-CDI Understanding the Burden of C. Difficile Infection Status COMPLETED Phase N/A
NCT03502681 A Study Combining Eribulin Mesylate With Avelumab in Cisplatin Ineligible Metastatic Urothelial Cell Cancer Patients Status TERMINATED Phase PHASE1
NCT03502616 Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) Status COMPLETED Phase PHASE3
NCT03499353 Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer Status TERMINATED Phase PHASE2
NCT03498378 Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03498196 A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03495791 Educational Intervention to Improve Patient-Physician Awareness of Cardiovascular Risk in Rheumatoid Arthritis. Status COMPLETED Phase NA
NCT03494816 Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion Status COMPLETED Phase PHASE2
NCT03492697 A Single Dose Crossover Study In Healthy Subjects To Evaluate Different Formulations Of PF-06882961 Status COMPLETED Phase PHASE1